| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MEDP | Common Stock | Sale | $1,931,139 | -10,540 | -0.17% | $183.22 | 6,189,188 | 12 Jul 2021 | Direct | F1, F2 |
| transaction | MEDP | Common Stock | Sale | $2,387,628 | -13,050 | -0.21% | $182.96 | 6,176,138 | 13 Jul 2021 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. |
| F2 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.715 to $184.76. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| F3 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $181.325 to $184.59. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |